Endocrine side effects of immune checkpoint inhibitors

被引：18

作者：

Cardona, Zulma ^{[1
]}

Sosman, Jeffrey A. ^{[2
]}

Chandra, Sunandana ^{[2
]}

Huang, Wenyu ^{[1
]}

机构：

[1] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA

[2] Northwestern Univ, Div Hematol & Oncol, Feinberg Sch Med, Chicago, IL USA

来源：

FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷

关键词：

immune checkpoint inhibitor (ICI); endocrine side effects; hypophysitis; thyroiditis; type1; diabetes; adrenalitis; adrenal insufficiency; central diabetes insipidus; IPILIMUMAB-INDUCED HYPOPHYSITIS; CELL LUNG-CANCER; QUALITY-OF-LIFE; ADVERSE EVENTS; RETROSPECTIVE ANALYSIS; ADRENAL INSUFFICIENCY; THYROID ANTIBODIES; PD-1; EXPRESSION; NIVOLUMAB; MANAGEMENT;

D O I：

10.3389/fendo.2023.1157805

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Immune checkpoint inhibitors (ICIs) have increasingly been the mainstay of treatment for numerous malignancies. However, due to their association with autoimmunity, ICIs have resulted in a variety of side effects that involve multiple organs including the endocrine system. In this review article, we describe our current understanding of the autoimmune endocrinopathies as a result of the use of ICIs. We will review the epidemiology, pathophysiology, clinical presentation, diagnosis, and management of the most commonly encountered endocrinopathies, including thyroiditis, hypophysitis, Type 1 diabetes, adrenalitis, and central diabetes insipidus.

引用

页数：12

共 50 条

[1] Immune checkpoint inhibitors and endocrine side effects, a narrative review
Agrawal, L.
Bacal, A.
Jain, S.
Singh, V
Emanuele, N.
Emanuele, Ma
Meah, F.
POSTGRADUATE MEDICINE, 2020, 132 (02) : 206 - 214
[2] The Diagnosis and Management of Endocrine Side Effects of Immune Checkpoint Inhibitors
Mai, Knut
Fassnacht, Martin
Fuehrer-Sakel, Dagmar
Honegger, Juergen B.
Weber, Matthias M.
Kroiss, Matthias
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2021, 118 (23): : 389 - +
[3] How we treat endocrine complications of immune checkpoint inhibitors
Paschou, S. A.
Stefanaki, K.
Psaltopoulou, T.
Liontos, M.
Koutsoukos, K.
Zagouri, F.
Lambrinoudaki, I
Dimopoulos, M-A
ESMO OPEN, 2021, 6 (01)
[4] Endocrine Side Effects Induced by Immune Checkpoint Inhibitors
Corsello, Salvatore Maria
Barnabei, Agnese
Marchetti, Paolo
De Vecchis, Liana
Salvatori, Roberto
Torino, Francesco
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (04) : 1361 - 1375
[5] Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review
Profili, Nicia I.
Castelli, Roberto
Gidaro, Antonio
Merella, Alessandro
Manetti, Roberto
Palmieri, Giuseppe
Maioli, Margherita
Delitala, Alessandro P.
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (15)
[6] Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society
Kwon, Hyemi
Roh, Eun
Ahn, Chang Ho
Kim, Hee Kyung
Ku, Cheol Ryong
Jung, Kyong Yeun
Lee, Ju Hee
Kim, Eun Heui
Suh, Sunghwan
Hong, Sangmo
Ha, Jeonghoon
Moon, Jun Sung
Kim, Jin Hwa
Kim, Mi-Kyung
ENDOCRINOLOGY AND METABOLISM, 2022, 37 (06) : 839 - 850
[7] Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know)
Ruggeri, R. M.
Campenni, A.
Giuffrida, G.
Trimboli, P.
Giovanella, L.
Trimarchi, F.
Cannavo, S.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (07) : 745 - 756
[8] Endocrinological side-effects of immune checkpoint inhibitors
Torino, Francesco
Corsello, Salvatore M.
Salvatori, Roberto
CURRENT OPINION IN ONCOLOGY, 2016, 28 (04) : 278 - 287
[9] Immune checkpoint inhibitors side effects and management
Kourie, Hampig Raphael
Klastersky, Jean
IMMUNOTHERAPY, 2016, 8 (07) : 799 - 807
[10] Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient?
Ozyurt, Esra
Ozcelik, Serhat
Surmeli, Heves
Celik, Mehmet
Ayhan, Murat
Ozcelik, Melike
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (02) : 462 - 465

← 1 2 3 4 5 →